![](/img/cover-not-exists.png)
Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
Phillips, D C, Xiao, Y, Lam, L T, Litvinovich, E, Roberts-Rapp, L, Souers, A J, Leverson, J DVolume:
5
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2015.88
Date:
November, 2015
File:
PDF, 2.86 MB
english, 2015